UNSPSC 85813115: Introduction of monoclonal antibody into biliary and pancreatic tract, via natural or artificial opening endoscopic

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of monoclonal antibody into biliary and pancreatic tract, via natural or artificial opening endoscopic. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0J80M

UNSPSC 85813115, Introduction of monoclonal antibody into biliary and pancreatic tract via natural or artificial opening endoscopic, is a Commodity code that shows no relevant recent state and local procurement activity. The four opportunities posted under or near this code involve virtual urgent care services, general medical services, PACE operations, and nursing home placement—none of which align with the specialized interventional gastroenterology procedure the code describes. The mismatch between the code's clinical specificity and the actual work being solicited suggests that either the code has been misapplied to these opportunities or the code itself sees minimal use in state and local purchasing.

The issuing bodies in the recent-opportunities block span health plans, counties, health authorities, and specialty districts across California, Georgia, and Nevada, but their solicitations address primary care networks, elderly services, and integrated care models rather than monoclonal antibody infusions for biliary or pancreatic conditions. No representative opportunities exist that would signal active procurement demand for this procedure code. State and local agencies do not appear to be buying this service through standard procurement channels at present.